In addition, a reduction in CS, measured by frequency doubling technology, has been associated with Aβ and P-Tau brain deposition as well as neurodegeneration, both throughout disease progression and alone in subjects at high risk for AD development (Risacher et al., 2020). Here, MAPT is linked to Alzheimer disease.